All Curated Mutation Sites in HTLV1

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HTLV1 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: Paraparesis, Tropical Spastic-26472535

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	26472535	151_161del			Paraparesis, Tropical Spastic	S L	View
2	26472535	A207G			Paraparesis, Tropical Spastic	S L	View
3	26472535	A298G			Paraparesis, Tropical Spastic	S L	View
4	26472535	C167T			Paraparesis, Tropical Spastic	S L	View
5	26472535	C215T			Paraparesis, Tropical Spastic	S L	View
6	26472535	C219G			Paraparesis, Tropical Spastic	S L	View
7	26472535	C219T			Paraparesis, Tropical Spastic	S L	View
8	26472535	C268T			Paraparesis, Tropical Spastic	S L	View
9	26472535	C479T			Paraparesis, Tropical Spastic	S L	View
10	26472535	G126C			Paraparesis, Tropical Spastic	S L	View
11	26472535	G126T			Paraparesis, Tropical Spastic	S L	View
12	26472535	G153A			Paraparesis, Tropical Spastic	S L	View
13	26472535	G199A			Paraparesis, Tropical Spastic	S L	View
14	26472535	G306A			Paraparesis, Tropical Spastic	S L	View
15	26472535	G306C			Paraparesis, Tropical Spastic	S L	View
16	26472535	T165C			Paraparesis, Tropical Spastic	S L	View
17	26472535	T301A			Paraparesis, Tropical Spastic	S L	View
18	26472535	T301C			Paraparesis, Tropical Spastic	S L	View
19	26472535	T345C			Paraparesis, Tropical Spastic	S L	View

Contents
Description

The table shows all curated mutation sites of HTLV1 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.